SCHEMBL32669694

SCHEMBL32669694

COc1cc(/C(O)=C(\C#N)C(=O)N(C)CC#Cc2ccc(F)cc2)cc([N+](=O)[O-])c1O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FTO Q9C0B1 7/20 0.47
COMT P21964 5/20 0.47
TTR P02766 2/20 0.43
EGFR P00533 2/20 0.39
KMT2A Q03164 3/20 0.35
MAPT P10636 3/20 0.35
MEN1 O00255 2/20 0.35
ALDH1A1 P00352 2/20 0.35
LMNA P02545 1/20 0.35
MCL1 Q07820 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
GAA P10253 2/20 0.35
JUN P05412 1/20 0.35
ABCB1 P08183 1/20 0.35
ABCC1 P33527 1/20 0.35
HPGD P15428 1/20 0.34
HTT P42858 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
KDM4E B2RXH2 1/20 0.34
NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32670000 0.92 FTO (0.49) FTOCOMTTTREGFRKMT2A
SCHEMBL32670020 0.92 FTO (0.46) FTOCOMTTTREGFRKMT2A
SCHEMBL32669908 0.90 FTO (0.49) FTOCOMTTTREGFRKMT2A
SCHEMBL32669704 0.90 FTO (0.60) FTOCOMTTTRKMT2AMAPT
SCHEMBL32669789 0.87 FTO (0.48) FTOCOMTTTREGFRKMT2A
SCHEMBL32670142 0.86 FTO (0.51) FTOCOMTTTREGFRMAPT
SCHEMBL32670049 0.86 FTO (0.53) FTOCOMTTTREGFRKMT2A
SCHEMBL32669607 0.85 FTO (0.49) FTOCOMTTTREGFRKMT2A
SCHEMBL32669670 0.85 FTO (0.47) FTOCOMTTTREGFRKMT2A
SCHEMBL32670126 0.85 FTO (0.56) FTOCOMTTTREGFRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260035341-A1 FTO INHIBITORS RPXDS CO LTD (CN) 2026-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260035341-A1 FTO INHIBITORS FTO, LDLR, GPR119 FTO 1/4885COMT 52/4885TTR 655/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.